16 Active Studies

Thyroid Disease Clinical Trials Near You

Find 16 actively recruiting thyroid disease research studies near you. Connect with study sites, check eligibility, and explore new treatment options.

16Active Trials
68+Locations
5,692Participants Needed

Recruiting Studies

Advanced Search

Data: ClinicalTrials.gov · Source of record for eligibility and locations

Top Cities for Thyroid Disease Clinical Trials

Thyroid Disease clinical trials are recruiting across 68 cities. Here are the cities with the most active studies:

Thyroid Disease Trial Phases

PHASE2(6 studies)
PHASE3(4 studies)
PHASE4(2 studies)
PHASE1(2 studies)
NA(1 study)

14 research organizations are sponsoring thyroid disease trials.

About Thyroid Disease

Thyroid disease encompasses conditions that affect the thyroid gland, including hypothyroidism (underactive), hyperthyroidism (overactive), Hashimoto's thyroiditis, and Graves' disease. The thyroid produces hormones that regulate metabolism. Treatment depends on the type and may include medication, radioactive iodine, or surgery.

Clinical trials are advancing new treatments for thyroid disease. Currently, 16 studies are recruiting a combined 5,692 participants across the United States. Research is being conducted by 14 organizations including National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), University of Michigan, Neuvosyn Laboratories, LLC and 11 others.

2026 Thyroid Disease Research Landscape

As of October 2026, the thyroid disease clinical trial landscape includes 16 actively recruiting studies across 68 cities in the United States. These studies are collectively seeking 5,692 participants, with an average enrollment target of 356 per study.

The research spans multiple phases of development: 6 studies are in PHASE2, 4 studies are in PHASE3, 2 studies are in PHASE4, 2 studies are in PHASE1, 1 study is in NA. The presence of Phase 3 trials indicates that some thyroid disease treatments are in late-stage testing and may be approaching regulatory review.

Research is being led by 14 different organizations, including National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), University of Michigan, Neuvosyn Laboratories, LLC, Biohaven Therapeutics Ltd., Immunovant Sciences GmbH, and 9 others. The large number of sponsors reflects significant research interest and investment in thyroid disease treatment advancement.

Geographically, thyroid disease trials are most concentrated in Miami, Florida (6 trials); San Francisco, California (4 trials); Walnut Creek, California (3 trials); Tucson, Arizona (3 trials); Doral, Florida (3 trials) and 7 other cities.

Featured Thyroid Disease Studies

Highlighted recruiting studies for thyroid disease, selected by enrollment size and research scope.

RecruitingNCT00001159

Natural History of Thyroid Function Disorders

Participants in this study will be patients diagnosed with or suspected to have a thyroid function disorder. These conditions may include: hypothyroidism, hyperthyroidism, thyroid hormone resistance, Graves' Dermopathy, and thyroid-stimulating hormone (TSH) secreting pituitary adenomas. The main purpose of this study is to further understand the natural history, clinical presentation, and genetic...

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)· 2,500 participants· 1 location (Bethesda)
View full study details →
RecruitingNCT06629272 · NA

Optimizing Care for Older Adults Through Thyroid Hormone Deprescribing

The proposed study focuses on testing a novel adapted evidence-based multilevel intervention, Deprescribing Thyroid Hormone In Older Adults (D-THIO), to support thyroid hormone deprescribing (dose de-escalation and/or discontinuation) in older adults with thyroid hormone overtreatment and/or misuse and reduce patient harm. Findings from this study will lay the groundwork for broad implementation o...

Sponsor: University of Michigan· 900 participants· 3 locations (San Francisco, Ann Arbor, Detroit)
View full study details →
RecruitingNCT07747103 · PHASE3

An Open-Label, Single-Arm Study to Investigate the Efficacy and Safety of North Star Desiccated Porcine Thyroid Extract Tablets.

The North Star study is a multi-center, Phase 3, open-label, single-arm clinical study to evaluate the Efficacy and Safety of North Star therapy.

Sponsor: Neuvosyn Laboratories, LLC· 466 participants· 10 locations (Modesto, Redding, San Diego, Walnut Creek)
View full study details →

Frequently Asked Questions About Thyroid Disease Clinical Trials

Are there thyroid disease clinical trials near me?

Yes, there are 16 thyroid disease clinical trials currently recruiting across 68+ cities in the United States, including Miami, Florida; San Francisco, California; Walnut Creek, California. Browse the studies above to find one at a location convenient for you.

How do I join a thyroid disease clinical trial?

To join a thyroid disease clinical trial: 1) Browse the available studies on this page, 2) Click on a study that interests you, 3) Check the study locations to find a site near you, 4) Review the eligibility criteria, and 5) Contact the study site or complete the eligibility form. The process is free and you can withdraw at any time.

Are thyroid disease clinical trials free?

Yes, participation in thyroid disease clinical trials is free. Study-related treatments, medical tests, and doctor visits are provided at no cost to participants. Many studies also offer compensation for your time and travel expenses.

What types of thyroid disease treatments are being studied?

Current thyroid disease clinical trials are testing a range of approaches across PHASE2 (6 studies), PHASE3 (4 studies), PHASE4 (2 studies), PHASE1 (2 studies), NA (1 study). These include new drugs, combination therapies, medical devices, and other interventions sponsored by 14 research organizations.

Is it safe to participate in thyroid disease clinical trials?

Clinical trials are carefully regulated by the FDA and institutional review boards (IRBs). All trials must follow strict safety protocols, and participants receive close medical monitoring throughout the study. You can withdraw from a trial at any time without penalty.

Data updated October 16, 2026 from ClinicalTrials.gov

About This Data

Data: ClinicalTrials.gov · Source of record for eligibility and locations

Clinical trial information on this page is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health (NIH) and National Library of Medicine (NLM). Study data is refreshed every hour to ensure accuracy.

Medical Disclaimer: The information provided on this page is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before making decisions about clinical trial participation or changes to your treatment plan.

Page reviewed by the HelloStudys Research Team · Last updated October 16, 2026 · Data from ClinicalTrials.gov